{
  "actions": [
    {
      "acted_at": "2019-05-21", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2019-05-21", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1584-116", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "B001267", 
      "district": null, 
      "name": "Bennet, Michael F.", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-05-21", 
      "state": "CO", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "B001277", 
      "district": null, 
      "name": "Blumenthal, Richard", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-05-21", 
      "state": "CT", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "H001075", 
      "district": null, 
      "name": "Harris, Kamala D.", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-05-21", 
      "state": "CA", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2019-05-21", 
  "number": "1584", 
  "official_title": "A bill to hold pharmaceutical companies accountable for dubious marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic in the United States.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr2917-116", 
      "identified_by": "CRS", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "Opioid Crisis Accountability Act of 2019", 
  "sponsor": {
    "bioguide_id": "S000033", 
    "district": null, 
    "name": "Sanders, Bernard", 
    "state": "VT", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2019-05-21", 
  "subjects": [
    "Child health", 
    "Civil actions and liability", 
    "Consumer affairs", 
    "Corporate finance and management", 
    "Criminal procedure and sentencing", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Government studies and investigations", 
    "Government trust funds", 
    "Health", 
    "Health care coverage and access", 
    "Health programs administration and funding", 
    "Marketing and advertising", 
    "Prescription drugs", 
    "Securities", 
    "Wages and earnings"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to hold pharmaceutical companies accountable for dubious marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic in the United States.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Opioid Crisis Accountability Act of 2019", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Opioid Crisis Accountability Act of 2019", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Opioid Crisis Accountability Act of 2019", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-07-16T09:29:20Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s1584.xml"
}